The Valley Desk

NCT03505021 · Interventional trial

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

Overall registry status Completed

Phase 3

Conditions Amyotrophic Lateral Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov